Cargando…
Clinical significance of standardized uptake value and maximum tumor diameter in patients with primary extranodal diffuse large B cell lymphoma
BACKGROUND: Maximum standardized uptake value (SUVmax) and maximum tumor diameter (MTD) have been shown to reflect survival outcome in diffuse large B cell lymphoma (DLBCL). However, applying these values to primary extranodal DLBCL is difficult because they are separate nosological entities with di...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3464338/ https://www.ncbi.nlm.nih.gov/pubmed/23071476 http://dx.doi.org/10.5045/kjh.2012.47.3.207 |
_version_ | 1782245412805017600 |
---|---|
author | Oh, Min-Young Oh, Sang-Bo Seoung, Hyeog-Gyu Kim, Ji-Hye Kim, Sang-Mi Kim, Tae-Kyun Song, Moo-Kon Shin, Ho-Jin Chung, Joo-Seop |
author_facet | Oh, Min-Young Oh, Sang-Bo Seoung, Hyeog-Gyu Kim, Ji-Hye Kim, Sang-Mi Kim, Tae-Kyun Song, Moo-Kon Shin, Ho-Jin Chung, Joo-Seop |
author_sort | Oh, Min-Young |
collection | PubMed |
description | BACKGROUND: Maximum standardized uptake value (SUVmax) and maximum tumor diameter (MTD) have been shown to reflect survival outcome in diffuse large B cell lymphoma (DLBCL). However, applying these values to primary extranodal DLBCL is difficult because they are separate nosological entities with differences in genetic origin. We therefore decided to evaluate whether SUVmax and MTD on 2-[fluorine-18]-fluoro-2-deoxy-D-glucose (18-FDG) positron emission tomography (PET) would affect the survival outcome in primary extranodal DLBCL. METHODS: From October 2005 to November 2010, 76 primary extranodal DLBCL patients receiving R-CHOP therapy were analyzed. All patients had undergone an initial 18-FDG PET/CT and conventional computed tomography (CT) of the neck, chest, abdomen, and pelvis for staging. Median follow-up period was 35 months. RESULTS: The SUVmax and MTD cut-off values were 11.0 and 7.5 cm, respectively. SUVmax≥11.0 predicted a short progression free survival (PFS, P=0.002) and overall survival (OS, P=0.002). MTD≥7.5 cm was associated with poor PFS (P=0.003) and OS (P=0.003). High International Prognostic Index (IPI) was also associated with the survival outcome (PFS, P=0.046; OS, P=0.030). Multivariate analysis revealed that SUVmax≥11.0 (PFS, hazard ratio [HR]=10.813, P=0.024; OS, HR=6.312, P=0.015); MTD≥7.5 cm (PFS, HR=5.631, P=0.008; OS, HR=4.072, P=0.008); and high IPI (PFS, P=0.027; OS, P=0.046) were independent prognostic factors. CONCLUSION: It appears that both MTD and SUVmax can be independent prognostic factors in primary extranodal DLBCL. |
format | Online Article Text |
id | pubmed-3464338 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis |
record_format | MEDLINE/PubMed |
spelling | pubmed-34643382012-10-15 Clinical significance of standardized uptake value and maximum tumor diameter in patients with primary extranodal diffuse large B cell lymphoma Oh, Min-Young Oh, Sang-Bo Seoung, Hyeog-Gyu Kim, Ji-Hye Kim, Sang-Mi Kim, Tae-Kyun Song, Moo-Kon Shin, Ho-Jin Chung, Joo-Seop Korean J Hematol Original Article BACKGROUND: Maximum standardized uptake value (SUVmax) and maximum tumor diameter (MTD) have been shown to reflect survival outcome in diffuse large B cell lymphoma (DLBCL). However, applying these values to primary extranodal DLBCL is difficult because they are separate nosological entities with differences in genetic origin. We therefore decided to evaluate whether SUVmax and MTD on 2-[fluorine-18]-fluoro-2-deoxy-D-glucose (18-FDG) positron emission tomography (PET) would affect the survival outcome in primary extranodal DLBCL. METHODS: From October 2005 to November 2010, 76 primary extranodal DLBCL patients receiving R-CHOP therapy were analyzed. All patients had undergone an initial 18-FDG PET/CT and conventional computed tomography (CT) of the neck, chest, abdomen, and pelvis for staging. Median follow-up period was 35 months. RESULTS: The SUVmax and MTD cut-off values were 11.0 and 7.5 cm, respectively. SUVmax≥11.0 predicted a short progression free survival (PFS, P=0.002) and overall survival (OS, P=0.002). MTD≥7.5 cm was associated with poor PFS (P=0.003) and OS (P=0.003). High International Prognostic Index (IPI) was also associated with the survival outcome (PFS, P=0.046; OS, P=0.030). Multivariate analysis revealed that SUVmax≥11.0 (PFS, hazard ratio [HR]=10.813, P=0.024; OS, HR=6.312, P=0.015); MTD≥7.5 cm (PFS, HR=5.631, P=0.008; OS, HR=4.072, P=0.008); and high IPI (PFS, P=0.027; OS, P=0.046) were independent prognostic factors. CONCLUSION: It appears that both MTD and SUVmax can be independent prognostic factors in primary extranodal DLBCL. Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2012-09 2012-09-25 /pmc/articles/PMC3464338/ /pubmed/23071476 http://dx.doi.org/10.5045/kjh.2012.47.3.207 Text en © 2012 Korean Society of Hematology http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Oh, Min-Young Oh, Sang-Bo Seoung, Hyeog-Gyu Kim, Ji-Hye Kim, Sang-Mi Kim, Tae-Kyun Song, Moo-Kon Shin, Ho-Jin Chung, Joo-Seop Clinical significance of standardized uptake value and maximum tumor diameter in patients with primary extranodal diffuse large B cell lymphoma |
title | Clinical significance of standardized uptake value and maximum tumor diameter in patients with primary extranodal diffuse large B cell lymphoma |
title_full | Clinical significance of standardized uptake value and maximum tumor diameter in patients with primary extranodal diffuse large B cell lymphoma |
title_fullStr | Clinical significance of standardized uptake value and maximum tumor diameter in patients with primary extranodal diffuse large B cell lymphoma |
title_full_unstemmed | Clinical significance of standardized uptake value and maximum tumor diameter in patients with primary extranodal diffuse large B cell lymphoma |
title_short | Clinical significance of standardized uptake value and maximum tumor diameter in patients with primary extranodal diffuse large B cell lymphoma |
title_sort | clinical significance of standardized uptake value and maximum tumor diameter in patients with primary extranodal diffuse large b cell lymphoma |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3464338/ https://www.ncbi.nlm.nih.gov/pubmed/23071476 http://dx.doi.org/10.5045/kjh.2012.47.3.207 |
work_keys_str_mv | AT ohminyoung clinicalsignificanceofstandardizeduptakevalueandmaximumtumordiameterinpatientswithprimaryextranodaldiffuselargebcelllymphoma AT ohsangbo clinicalsignificanceofstandardizeduptakevalueandmaximumtumordiameterinpatientswithprimaryextranodaldiffuselargebcelllymphoma AT seounghyeoggyu clinicalsignificanceofstandardizeduptakevalueandmaximumtumordiameterinpatientswithprimaryextranodaldiffuselargebcelllymphoma AT kimjihye clinicalsignificanceofstandardizeduptakevalueandmaximumtumordiameterinpatientswithprimaryextranodaldiffuselargebcelllymphoma AT kimsangmi clinicalsignificanceofstandardizeduptakevalueandmaximumtumordiameterinpatientswithprimaryextranodaldiffuselargebcelllymphoma AT kimtaekyun clinicalsignificanceofstandardizeduptakevalueandmaximumtumordiameterinpatientswithprimaryextranodaldiffuselargebcelllymphoma AT songmookon clinicalsignificanceofstandardizeduptakevalueandmaximumtumordiameterinpatientswithprimaryextranodaldiffuselargebcelllymphoma AT shinhojin clinicalsignificanceofstandardizeduptakevalueandmaximumtumordiameterinpatientswithprimaryextranodaldiffuselargebcelllymphoma AT chungjooseop clinicalsignificanceofstandardizeduptakevalueandmaximumtumordiameterinpatientswithprimaryextranodaldiffuselargebcelllymphoma |